chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe chills, body ,muscle, joint aches, fever and sweats. Some stomach cramping . These all lasted 7 hours. Next day still body aches, headache and fatigue.
Patient was administered the first dose of Moderna vaccine in April 21 but did not get the second dose (since 5 months ago); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient was administered the first dose of Moderna vaccine in April 21 but did not get the second dose (since 5 months ago)) in a 99-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Cardiac arrest (heart condition (pace maker  and defibrillator)).    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient was administered the first dose of Moderna vaccine in April 21 but did not get the second dose (since 5 months ago)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient was administered the first dose of Moderna vaccine in April 21 but did not get the second dose (since 5 months ago)) had resolved.            No Concomitant medications was provided.  No Treatment medications was provided.   Reporter did not allow further contact
At four minutes post injection patient complained of a funny taste in her mouth. Upon further questioning, patient stated she felt like she had phlegm in her throat, tightness in throat and hard time swallowing. PA with patient. Oral diphenhydramine administered eight minutes after injection, four minutes after first signs of reaction. After 30 minutes of observation, patient stated she felt better. Vital signs normal.
Pt reports she broke out in a rash all over and felt nauseated, she states she stayed home from school the next day due to still not feeling well.  Pt is in school today with no symptoms.
Person received vaccine around 8:30AM. Reported that she was shivering uncontrollably and her body turned ice cold starting that evening into next morning. Also feeling weak and fatigued that morning.
increase in rash on arms/hands/feet; sore arm; Redness; headache; Bodyache; joint pain in knees; This is solicited report received from the specialty pharmacy received from a contactable other HCP and consumers. other HCP reported that, A 73-year-old female patient received BNT162B2 ( Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number: unknown, Expiration date: unknown), via an unspecified route of administration on 18Mar2021 at Unknown dose, single for covid-19 immunization. Patient medical history included loose stools, itchy skin, anaemic with low haemoglobin, shortness of breath at times, tired, joint pain, blood pressure fluctuated with very low reading a few days ago, feeling lightheaded, lethargy, from an unknown date. The patient previously took lisinopril doubled lisinopril dosing (per md protocol) prior to checking it pushed fluids and improved, will notify md. it was reported that patient taking  sutent 25 mg daily for 3 weeks. On an unknown date in Mar2021, the patient experienced rash on arms/hands, sore arms, redness, headache, body ache and joint pain in knees. Since the vaccine the patient reported of increased rash on hands/arms/feet which seems to be stable now but not gone. The patient was treated with cortisone ointment for rash on hands/arms/feet. The outcome of the events increase in rash on arms/hands/feet was not recovered, while other events outcome were unknown.   No follow-up attempts are possible. No information about lot/batch number cannot be obtained; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate
Very sore arm. Mild swelling. Very painful to move my arm. Especially painful moving upwards over my head.
4mos p/vax pt devel rash w/some spots, fever 101f & dx w/otitis media; pt hospitalized
1st dose 5Jan2022, 2nd not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose on 5th January 2022, with batch number 53936 and expiry 1st April 2023).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 27-Feb-2023 Reporter's Comments: The patient did not receive the 2nd dose yet. The reporter did not consent to follow-up.  The Vaccine Administration Facility is the same as Primary Reporter. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Vomited & lightheaded 5 min after injected.  Resolved with rest.
Received the vaccine April 5th 2:00pm, April 6th around 9:00am I started feeling hot, slight fever and slight chills throughout the morning. Around 1:00pm it became worse.  Around 3:30 I had full fever of at least 101.5 with constant chills, felt very week with a headache and feeling like a sinus infection all lasting thru the evening.  My Wednesday morning April 7th temp was down to 101.1, still felt week, headache  and some sinus drainage .  I took Advil and Tylenol during this.  Didn?t felt the need to see a doctor.
no fever @ home 99.0a;MD ofc 23OCT;swelling under lt arm then under upper arm felt swelled but no redness;could not see swelled area could feel the swelling when moving arm;next day blotchy red area;dx cellulitis;pt concerned allerg to vax;
ENTIRE UPPER ARM NEAR INJECTION SITE WAS RED AND PAINFUL AND WARM TO TOUCH.
Feeling tired and ear ache on right side, sore throat on right side.  By 12/4/12, I was getting worst.  I had swollen lymph node behind right ear and /right tonsil was swollen.  Went to ER 12-27-12.  No throat cultures or labs.  Received 10 days of amoxicilin. Still tired, sore throat and ear pain. I went to the doctors, last week and the week before.  New doctors at facility.  Labs draw last week and in ER three days ago reveal low white count.  I'm still sick.
On 10/21/23 at approximately 0230 patient began to shake and appeared to be having a seizure. Postictal breathing pattern was noted, patient was very pale, and pupils were 1 mm and fixed. He took approximately 5 breaths, didn't respond to sternal rub. Unable to auscultate apical heart rate for greater than 60 seconds. Time of death noted as 0239.
WEAKNESS, HEAVY FEELING  , FEELING LIKE GOING TO PASS OUT, CHEST HEAVINESS
-Received COVID vaccine 2:15-2:30 pm -Felt fine during 15 minute observation -Came home (about 25 minute drive) -Put on new plastic gown to help 88 yo father sit up in his hospital bed. He was clean and dry. -As I was fiddling with the blue plastic gown, I felt mild itchiness on right forearm and started scratching. -I looked at right volar forearm (supine position) and noted about 6 raised 2-4 mm blanching bumps with central darkening (like a small scab almost) - 4 below antecubital fossa, one in the actual fossa and another one immediately proximal. Mild itching, nothing distressing.  -Lesions still persisting (To Dec 18). I am not scratching/taking anything for it. Lesions are visible. -No other family members (including father) with any skin rashes, no bed bugs, spouse who also lifts/cleans elderly father has no skin rashes -Evening of Dec 17 and persisting to mid day Dec 18: mild sore throat, nasal congestion, mild myalgia, fatigue, subjective fever but when took temp- no fever. Then all of a sudden, the sore throat/nasal congestion, myalgias, tiredness abated all around 3:30 pm. Skin lesions still present. -All of these symptoms were mild.  -Again, skin lesions on right volar forearm persist.
Blood in stool started 11/21/2021, one day after Covid vaccination Diagnosed with Ulcerative Colitis February 2022
Pain in actual site my shoulder is actually throbbing; Sore throat; This is a spontaneous report from a contactable consumer.   A 44Year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 02Jan2021 at single dose for COVID-19 immunization. The patient did not have medical history or concomitant medications. Patient informed she received the vaccine, her first round of dose yesterday at 2'O clock (02Jan2021) and she was experiencing pain in  her shoulder, that was actually throbbing. She also noticed it within a couple of hours, she had a sore throat. Treatment received included Aleve. At the time of the reporting event outcome was unknown.   Information on lot/ batch number has been requested.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 15-JUN-2017 the patient was vaccinated with an improperly stored dose of VARIVAX (lot # M002063; expiration date: 12-JAN-2018) (dose and route was not reported) for prophylaxis. Concomitant therapies included sterile diluent (lot # M006117; expiration date: 24-AUG-2048).  It was reported that the sterile diluent used to reconstitute the VARIVAX was properly stored. No symptoms were reported. Temperature that the vaccine was exposed was at 9 degrees Celsius to 25 degrees Celsius during 2 days. No previous temperature excursion was reported. Data Logger was not involved.
Patient returned to clinic after recieving vaccine stating that his left arm and left side felt numb as well as his mouth and tongue. This nurse immediately administered Epipen into left thigh while a provider near by was notified as well as other nursing staff. Patient "felt fine" and VS were stabkle. EMS transport notified for delivery to ER after administering EpiPen. While waiting for EMS (30 minute wait), patient begin to seize and was uncounscious. Patient was sitting upright in a chair. Sternal rub performed and patient was able to awaken with a steady pulse. Cold rags were applied for stimulation and sweating. EMS transport then arrived to take patient to the ER, as loading onto the stretcher, patient begin to seize again. Patient was then out of our care and sent to the ER. Patient was called at approx. 4:15 p.m. by this nurse for a wellness check. Patient stated she is fine and at home resting.
Initial report received on 26 Oct 2009 from a health care professional. A 16 year old male patient with a history of allergic rhinitis received FLUZONE on 19 September 2009 and H1N1 on 11 October 2009 (lot number, route and site were not provided). On an unspecified date, reported as "recently", the patient developed a fever and congestion. On 26 October 2009, the patient tested positive for Influenza A. Concomitant therapy included SINGULAIR 10 mg daily and inhalers (not specified). Recovery status was not reported. List of Documents held by Sender: none. 11/4/09 Medical records received for date 10/26/09 DX: fever after vaccine. Pt. presented to OV with fever. Pt received flu vax 9/19/09 and H1N1 vax 10/11/09.
the patient received the wrong vaccine and received Menactra; the patient received the wrong vaccine and received Menactra; the patient passed away due to unknown cause; Initial information received on 24-Aug-2020 regarding an unsolicited valid serious case received from a other health professional.  This case involves a 12-year-old male patient who passed away due to unknown cause (death) after receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA]. It was reported that the patient received the wrong vaccine and received Menactra (wrong product administered and extra dose administered).  The patient's medical history, past medical treatment(s), vaccination(s) and family history and concomitant therapies (if any) were not provided.   On 15-Oct-2019, the patient received a first dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number, expiry date, route and site of administration and other dosing details were not reported). On 12-Aug-2020, the patient received a second 0.5 ml dose of same vaccine (lot U6585AB, expiry date not reported) via intramuscular route in the left deltoid for prophylactic vaccination.  In Aug-2020, the patient passed away due to unknown cause (death) a week following the administration of second dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. This event was assessed as medically significant as it led to death. It was a case of actual medication error due to wrong vaccine administered and extra dose administered (Nurse stated that the patient received the wrong vaccine and received Menactra).  Relevant laboratory test(s) and corrective treatment (if any) were not reported.  The patient died on an unknown date. It was unknown if an autopsy was done. Reporter stated that cause of death was still being investigated.  Batch number has been requested.; Sender's Comments: This case involves a 12-year-old male patient, who died one week after the vaccination with MENACTRA. The time to onset is compatible. Additional information regarding patient's relevant medical history, health condition at time of vaccination, concomitant medication and investigations ruling out other alternative etiologies, autopsy results for cause of death would be needed for complete assessment of the case. Based on the reported information role of the vaccine cannot be assessed.; Reported Cause(s) of Death: the patient passed away due to unknown cause
Four days following vaccines he had a fever and a complex febrile seizure with seizure-like behavior greater than 15 minutes. He also had nasal congestion and cough at the time. He has fully recovered. In the ER he was given diazepam x 3 doses.
This is a 16-month-old female born full-term via vaginal delivery with no contributing comorbidities brought in by mother complaining of skin rash for 2 days.  Patient was evaluated emergency department 2 days ago for postvaccine fever and teething.  Since discharge, mother states patient has been afebrile that she has noticed a diffuse rash.  Patient has not been scratching at the rash but appears to be in discomfort and is fussier than normal.  She reports recent increase drooling due to teething.  Patient received influenza vaccine within the last week.  There is no associated vomiting, diarrhea, cough.  She has not noted increased work of breathing.  Normal wet diapers and bowel movements.  Mother reviewed symptoms as moderate in nature and rash remains unchanged with over-the-counter medication. Patient states that the rash is getting worse.  Patient has no history of the same.   The potential cause of the rash is unknown. Perioral crusted vesicular rash.  Vesicular rash noted diffusely to trunk and extremities is described as maculopapular, blanching without vesicles or petechiae.  No crepitus , cellulitis, fluctuance or induration noted. Patient has rash that is consistent with a impetigo, eczema and viral rash and therefore will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing, well hydrated, and playful. Based on the history, exam, and any testing done, I don't suspect an emergency cause of rash such as cellulitis, necrotizing fasciitis, vasculitis etc. Patient will be discharged with strict return precautions and follow up with primary MD within 24 hours for further evaluation.
Patient called on 10/16/14. She said she had chills, fever (100.1F), nausea, diarrhea, and a headache. She said it started the night of 10/15/14. I called the patient back at 9:30am on 10/17/14 and she said she was feeling much better.  I did talk to a family member of the patient, who actually came in with the patient when she recieved her vaccine, and the family member had stated that several members of the family who had all gotten together on 10/11/14 had experienced a similar sickness.
Patient reports mild body aches, cold sweats and fatigue. Also a mild sore throat and slight headache
This spontaneous report as received from a nurse refers to multiple unspecified patients. On unknown dates the patients were vaccinated with PROQUAD (lot #, expiration date, dose and route unspecified) that were stored improperly. No adverse effects reported. This is one of several reports received from same source. Additional information has been requested.
lt upper arm edematous to neck & painful @ rest w/movement chills, nausea & h/a;
lymph node was really swollen in left arm where I got shot; diarrhea; nauseated; vomiting; chilling really bad; fever/101°F; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), CHILLS (chilling really bad), PYREXIA (fever/101°F), NAUSEA (nauseated) and VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A, 019B21A and 017F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced CHILLS (chilling really bad) and PYREXIA (fever/101°F). On 27-Oct-2021, the patient experienced DIARRHOEA (diarrhea), NAUSEA (nauseated) and VOMITING (vomiting). On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY (lymph node was really swollen in left arm where I got shot). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. On 28-Oct-2021, DIARRHOEA (diarrhea), CHILLS (chilling really bad), PYREXIA (fever/101°F), NAUSEA (nauseated) and VOMITING (vomiting) had resolved. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (lymph node was really swollen in left arm where I got shot) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Oct-2021, Body temperature: 101°f (High) High.         No concomitant medication provided. Patient date of birth includes 28-OCT year was unknown
Mother reported red circle around injection site, approx size of a bouncy ball. Area was warm to touch and hard. Denied fevers. Mother was advised to place ice on the area and continue to monitor.   Next day, mother reported the area had improved, hardness had resolved and redness was decreasing.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live significant follow-up: updated I-narrative.
Mom stated that patient had " passed out with her last vaccine" Mom states this vaccines was an HPV . Prior to vaccine  had patient to lay down on exam table for shot. Vaccine given in right deltoid per  protocol pt tol well. Recommended patient lay for few minutes before sitting, pt  stated felt ok. Patient sat on exam table for approxmiate 5-10 minutes. Mother at  side. After approx 5-10 minutes pt moaned and had  syncopal episode with patient  lying back on table with color turning pale. Pt awake and talking within a few  seconds of episode. Pt's feet elevated, patient able to answer questions, b/p  106/78 heart rate 68 and regular. Notified Dr, she stated to check another  blood pressure before patient released. B/P rechecked approx 10 minutes later with  bp 106/72 hr 57. Patient's color back to normal , patient stated she felt better.  Patient sat in exam room in upright approx 20 minutes beforing leaving with  mother. Patient stated she felt better. Encouraged if any more issues patient  should see a health care provider.
pt recv vax & felt unwell & was irritable; pt devel a fever of 101 & chickenpox; seen in MD office 50-100 lesions & scabbed lesions w/o vesicles; 3 pustules aspirated;
Patient developed the usual expected vaccine symptoms the night after J&J vaccine HA/body aches, then woke up with chest pain the next morning. Came in for eval 1 week later. Pain is constant, dull ache, relieved when leaning forward. Associated fatigue. Positive pericardial friction rub on exam. Labs and ekg within normal limits.  He had no relief with ibuprofen. Discharged on colchicine with urgent cardiology referral and follow up.
pale, weak, pulse 68, blurred vision, bellyache; lowered head observation-subsided over 15-20mins;
Premature Ventricular Contractions.  Irregular heart beats, out of breath from low exercise, fatigue.
Given Thurs. 10/1/15 8am. Fri at 2:30am had been fine broke out in hives dime size immediately after that she had an asthma attack immed. went to ER.
Right shoulder area became warm and erythematous, extending throughout deltoid area within hours after vaccine administration. He had tender axillary adenopathy over a similar time course. He reported to my clinic 2 days after vaccine administration. No fevers, headaches. Will treat with ice and ibuprofen.